Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Renin Angiotensin System Blockage-DN (RASS)

NCT00143949 is registered in ClinicalTrials.gov with Michael Mauer, MD as lead sponsor.

NCT NCT00143949
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00143949 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Renin Angiotensin System Blockage-DN (RASS)
Lead sponsor
Michael Mauer, MD
Phase
Phase 2
Overall status
Completed
Start date
March 31, 1997
Completion date
May 31, 2008
Enrollment
285 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes